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Abstract
Introduction : Erythropoietin (EPO) is the major regulating blood flow hormone that
managing the sustaining hematopoiesis and through inhibition of apoptosis of erythroid
precursors category is lead to proliferation and differentiation to normoblast and also increase the
life span of red blood cells from fetal to neonatal and maturation. Premature anemia that
constantly seen in low birth weight premature infants that is a hypo generator anemia and usually
appear in the second week and reaches its severity to two months. This study examined the
effectiveness of intravenous recombinant erythropoietin regimen associated with oral iron and
oral iron regimen in hematopoiesis of premature infants.
Material and Methods : This study is a clinical trial. In current study were participated very
low and premature infants with weight less than or equal to 1500 g and gestational age less than
34 weeks and were divided in to two groups of 40 persons. First group received intravenous
recombinant erythropoietin (with 1200 units per kg weight in week (3 days)) associated with iron
drip and second group were randomly selected as control group and iron administrated only.
Then reticulocyte, serum erythropoietin and ferritin were measured in admission, before
discharge and three months after discharge. All information of patients associated with
demographic information was entered in check lists then resulted data were analyzed by SPSS
v16 software.
Results: In this study 80 infants were enrolled that in case group 25 persons (62.5%) were girl
and in control group 24 persons (60%) were boy and also the average age of these pre term
infants in cases was 1273.75 ±198.38 gr and in controls was 1223.75 ±217.49 gr. Results showed
that ferritin injection could inhibit the decrease in hemoglobin and ferritin significantly; and also
leads to decline in reticulcytes levels in patients and controls significantly.
Conclusion: This study showed that injection of erythropoietin in premature infants leads to
increased levels of reticulocyte hemoglobin and ferritin levels and this finding is similar to
majority of studies.
Key Words: Erythropoietin, Iron therapy, VLBW infant
Comparison efficacy of recombinant erythropoietin and iron therapy with alone iron therapy in
hematopoiesis of very low birth weight infant admitted in NICU
